Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Pifusertib (TAS-117) | 1402602-94-1 | 98.7% | 424.49 g·mol⁻¹ | C26H24N4O2 | 10 MG
SDP

Catalog No. 5000297198
Encompass_Preferred

Pifusertib (TAS-117) is a potent, selective, orally active allosteric Akt inhibitor provided for research use. Supplied in milligram-scale packs, it is intended for preclinical biochemical and cellular studies probing Akt signaling. The compound includes specified physicochemical identifiers and high-performance liquid chromatography data for reproducible experimental application.

  • Potent, selective allosteric Akt inhibitor.
  • Orally active, suitable for in vivo preclinical models.
  • High purity: 98.7% (HPLC) for analytical consistency.
  • Molecular weight 424.49 g·mol⁻¹; formula C26H24N4O2.
  • Available in milligram-scale packs for laboratory use.
  • For research use only; not for human or clinical use.

Catalog No. 50-002-97198 Supplier Medchemexpress LLC Supplier No. HY1993410MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Pifusertib (TAS-117) is a potent, selective, orally active allosteric Akt inhibitor provided for research use. Supplied in milligram-scale packs, it is intended for preclinical biochemical and cellular studies probing Akt signaling. The compound includes specified physicochemical identifiers and high-performance liquid chromatography data for reproducible experimental application.

  • Potent, selective allosteric Akt inhibitor.
  • Orally active, suitable for in vivo preclinical models.
  • High purity: 98.7% (HPLC) for analytical consistency.
  • Molecular weight 424.49 g·mol⁻¹; formula C26H24N4O2.
  • Available in milligram-scale packs for laboratory use.
  • For research use only; not for human or clinical use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.